2, active nucleic acid test. Returning to Handan personnel to strictly implement the requirements of nucleic acid testing, that is: before coming to Handan must be held within 24 to 48 hours of a negative nucleic acid test certificate, in the traffic jam to Handan for a landing nucleic acid test, arrived at the destination 24 hours after 48 hours to carry out another nucleic acid test on their own.
A key group of people "should be examined as much as possible".
1. close contacts;
2. foreign entrants;
3. fever clinic patients;
4. newly hospitalized patients and accompanying staff;
5. medical institution staff;
6. port quarantine and border control personnel;
7. prison staff;
II. Strengthening organization and management, and increasing protection
(1) Strengthening organizational leadership. Local party committees and governments at all levels should take the strengthening of detection as an important element of the current regular epidemic prevention and control work, strengthen leadership and careful organization. Joint prevention and control mechanisms at all levels (leading groups and commands) should formulate work programs, implement departmental responsibilities, hold regular coordination meetings, study and solve key and difficult problems in expanding nucleic acid testing, do a good job in assessing public opinion and responding to risks, and make timely and dynamic adjustments according to the situation of epidemic prevention and control.
(ii) Strengthening policy support. Local party committees and governments should study and formulate relevant policies and measures to rapidly enhance the capacity of nucleic acid testing, and mobilize social testing service agencies to carry out nucleic acid testing work actively. Provincial medical insurance departments in a timely manner and in accordance with the procedures of nucleic acid testing projects and related consumables into the province's medical insurance diagnostic and treatment program directory. Provincial pricing departments set fees for uniform implementation within the province.
(3) Increase financial security. Governments at all levels to strengthen funding arrangements for disease control agencies, medical institutions, customs laboratory construction and testing equipment to be equipped with financial support, in particular, to increase the relatively dense population, mobility areas and border crossings and other key areas of support. Where conditions exist, testing reagents and consumables will be included in the procurement scope of the provincial centralized procurement platform and the bidding and procurement procedures will be simplified. "Should be tested" the costs borne by local governments, "willing to test" the costs borne by enterprises and institutions or individuals.
Three, accelerate the enhancement of testing capacity, to meet the demand for testing
(a) Strengthen the construction of laboratories. All localities should strengthen the tertiary hospitals, hospitals specializing in infectious diseases, county (district) level and above, CDC agencies, customs and county hospitals with the conditions of laboratory construction, so that they have the ability to carry out the new coronavirus testing. For the relative lack of medical resources, relatively weak testing capacity, epidemic prevention and control pressure on the land border cities, the CDC agencies, customs and a strong integrated strength of the medical institutions to be focused on supporting, if necessary, mobile square cabin laboratory. Synchronized to strengthen other hospitals above the second level, specialized hospitals, maternal and child health hospitals laboratory construction, so that they gradually meet the new coronavirus nucleic acid testing conditions.
(ii) Strengthening quality control and biosafety. Strengthen the laboratory capacity building standards system certification and laboratory indoor quality control, regular acceptance of national or provincial clinical testing quality control. Provincial health administrative departments to organize the jurisdiction of the testing institutions in batches to participate in the inter-room quality assessment, to ensure that each institution to participate in at least one inter-room quality assessment per year. Testing organizations to strengthen biosafety management, strict operational procedures, proper disposal of the remaining biological samples, sample use, preservation, uploading and destruction.
Legal basis:
"The People's Republic of China*** and the Prevention and Control of Infectious Diseases Act"
Article XII
In the People's Republic of China*** and the territory of the State of all units and individuals must be subject to disease prevention and control agencies, medical institutions related to the prevention and control of infectious diseases of the investigation, testing, collection of samples, quarantine Treatment and other preventive and control measures, and truthfully provide relevant information. Disease prevention and control institutions, medical institutions shall not disclose information related to personal privacy.